Summary:
A 2 part study investigating the effects of TD-9855 for the treatment of orthostatic hypotension due to Parkinsons, multiple system atrophy, or pure autonomic failure.
Qualified Participants Must:
Be diagnosed with symptomatic orthostatic hypotension due to Parkinson's disease, multiple system atrophy, or pure autonomic failure, (i.e. neurogenic orthostatic hypotension)
Be between 40 and 80 years of age
Qualified Participants May Receive:
Compensation for time and travel. Qualified participants may also receive investigational drug at no cost.